Privilege escalation in Oracle Corporation Siebel Apps - Life Sciences

CVE-2026-83193

Vulnerability in the Siebel Apps - Life Sciences product of Oracle Siebel CRM (component: Life Sciences). Supported versions that are affected are 17.0-26.7. Easily exploitable vulnerability allows low privileged attacker with logon to the infrastructure where Siebel Apps - Life Sciences executes to compromise Siebel Apps - Life Sciences. Successful attacks require human interaction from a person other than the attacker. Successful attacks of this vulnerability can result in takeover of Siebel Apps - Life Sciences. CVSS 3.1 Base Score 7.3 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:L/AC:L/PR:L/UI:R/S:U/C:H/I:H/A:H).

Vulnerability class: Privilege Escalation

Published · last modified .

CVSS v3 metric

CVSS v3 base score 7.3 (High). Vector: CVSS:3.1/AV:L/AC:L/PR:L/UI:R/S:U/C:H/I:H/A:H.

EPSS exploit prediction

EPSS: 0.001 (3.3th percentile), scored .

Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 3rd percentile — 3.3% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.

EPSS trend (30 days)EPSS over the last 30 days for CVE-2026-83193: held from 0.001 to 0.001.

EPSS over last 30 days · oldest: 0.001 · newest: 0.001 · change: 0.000

Affected products

Weakness classification (CWE)

References

Frequently asked questions

What is CVE-2026-83193?
CVE-2026-83193 is a high-severity vulnerability in Oracle Corporation Siebel Apps - Life Sciences, classified under Improper Privilege Management. CVSS score: 7.3/10. Published 2026-09-15.
How severe is CVE-2026-83193?
High severity. CVSS v3 base score is 7.3 out of 10.